ReviewLife (Basel, Switzerland)2023

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer.

Alberto Verlicchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.